1 min read
On Demand Webinar: High-Speed Viral Drug Product Manufacturing
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line,...
Perfecting Your Formula
At Emergent CDMO, we are synchronized to serious science. Yours. Helping biopharma innovators bring life-saving, life-extending therapies to patients around the world is our mission. Whether your therapeutic or vaccine is centered on a global health risk, rare disease, or novel medicine, you'll find us a like-minded and more-than-capable partner.
Even when the world changes around us and new challenges emerge, our mission stays the same — to improve and protect the health of billions of people around the globe by supporting innovative drug makers that make the seemingly impossible possible. Read more about how our commitments to supporting regulatory compliance and quality excellence help biopharma innovators bring life-saving and life-extending therapies to patients throughout the world.
Wherever you might be in the drug product lifecycle, Emergent CDMO stands ready to put our resources, technology, and experience to work for you.
We understand that which approach fits you best can be found where science and business strategy intersect, where dynamics like speed, cost, and regulatory approach are balanced in precise harmony. And as an integrated CDMO with the experience of an established biopharmaceutical company, Emergent stands ready to help guide and advance your team down the straightest, smoothest development and manufacturing pathway.
Our clients have come to rely on Emergent CDMO for a broad range of development services, including process development for drug substance and drug product, and analytical development. Whether your program is in clinical or commercial phases, just starting up or scaling for growth, our development services are primed to plug in right where you need them.
When your unique science connects with our drug substance capabilities, promising opportunities abound. We tailor our suite of technology platforms (mammalian, microbial, plasma protein, and viral) to meet your precise needs. Then we leverage our resources capacity to support your goals.
Learn more about our Drug Substance Manufacturing capabilities
Leveraging both viral and non-viral technologies, our drug product manufacturing capabilities are designed to support all phases of your product lifecycle. Whether you need small volumes of material for clinical research or large-scale manufacturing for a commercialized product, Emergent CDMO has the production, filling, and packaging expertise to support your growth and scale-up, now and in the future.
Learn more about our Drug Product Manufacturing capabilities
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line,...
Located in Thörishaus, Switzerland, just outside of Bern, our European-based site has expertise in mammalian,...
Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from...
Global health risks. Rare disease therapeutics. Novel medicines. No matter where your innovation is centered, you'll find us a like-minded and more-than-capable partner. And, no matter where we begin with your project, we maintain a holistic perspective as we help you accelerate along your process development and manufacturing pathway.
“The Emergent Way” is visible in everything we do for you. The elements that define it aren’t labeled that way, of course, but you’ll see the hallmarks of what make us different at every turn.
Our team is dedicated to the art and science of “efficient excellence,” and we incorporate that into everything we do for you. That means we lean toward your interests and not away, and that you can count on us in both the most ordinary and most extraordinary of circumstances.
Your formula for success if just that - yours. Our size and operating philosophy afford us the ability to assemble the experts, services and technologies in the configurations that best meet your development and manufacturing needs.
At Emergent, our cross-functional teams arm you with the single most valuable asset you can have during tech transfers: confidence. We reduce risk by sticking to proven processes and by not just keeping you apprised of what we’re doing, but how and why we’re doing it.
Our team is dedicated to the art and science of “efficient excellence,” and we incorporate that into everything we do for you. That means we lean toward your interests and not away, and that you can count on us in both the most ordinary and most extraordinary of circumstances.
Every organization says the same thing. We get that. But not every company has a goal of protecting or enhancing a billion lives (which is what we aim to do by 2030). You’ll feel that enthusiasm, focus and dedication when you collaborate with your Emergent CDMO team.
10 Global CDMO facilities on two continents
40+ Commercial manufacturing programs supported
200+ Clinical
candidates supported
20+ Years of development & mfg. experience
70+ Global CDMO clients
7 fill lines available for CDMO clients